Therapy and prognostic factors in adult acute lymphoblastic leukaemia.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Bailliere's Clinical Haematology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 7803903
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of acute lymphoblastic leukemia.

  1994cited by this paper
• Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthracycline containing regimen.

  1993cited by this paper
• Philadelphia chromosome-positive acute lymphoblastic leukemia.

  1993cited by this paper
• Simultaneous administration of granulocyte colony-stimulating factor (Filgrastim) and induction chemotherapy in acute lymphoblastic leukemia

  1993cited by this paper
• Cancer and Leukemia Group B (CALGB) studies in adult acute lymhocytic leukemia.

  1992cited by this paper
• The German multicentre trials for treatment of acute lymphoblastic leukemia in adults. The German Adult ALL Study Group.

  1992cited by this paper
• Detection of BCR/ABL translocation by polymerase chain reaction in leukemic progenitor cells (ALL-CFU) from patients with acute lymphoblastic leukemia (ALL).

  1992cited by this paper
• Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). The EORTC Leukemia Cooperative Study Group.

  1992cited by this paper
• Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762).

  1992cited by this paper
• Clinical and prognostic significance of the Philadelphia chromosome in adult patients with acute lymphoblastic leukemia

  1992cited by this paper
• Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience.

  1992cited by this paper
• Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.

  1992cited by this paper
• Treatment of adult acute lymphoblastic leukaemia (ALL) over a 16 year period.

  1992cited by this paper
• Polymerase chain reaction analysis of BCR-ABL sequences in adult Philadelphia chromosome-negative acute lymphoblastic leukemia patients.

  1992cited by this paper
• Improved results of an intensified therapy in adult acute lymphocytic leukemia.

  1991cited by this paper
• Chemotherapy of adult acute lymphoblastic leukaemia.

  1991cited by this paper
• Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB Study.

  1991cited by this paper
• Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report.

  1991cited by this paper
• Detection of minimal residual disease in T-cell acute lymphoblastic leukemia using polymerase chain reaction predicts impending relapse.

  1991cited by this paper
• Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.

  1991cited by this paper
• The use of the polymerase chain reaction for the detection of minimal residual malignant disease.

  1991cited by this paper
• Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia.

  1991cited by this paper
• Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance.

  1991cited by this paper
• mdr‐1 GENE AMPLIFICATION IN ACUTE LYMPHOBLASTIC LEUKAEMIA PRIOR TO ANTILEUKAEMIC TREATMENT

  1991cited by this paper
• The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B.

  1991cited by this paper
• Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction.

  1991cited by this paper
• High-dose chemotherapy in adult acute lymphoblastic leukemia.

  1991cited by this paper
• Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia.

  1991cited by this paper
• [The treatment of acute lymphatic leukemia in adults: pilot project with intensive early therapy without a maintenance phase].

  1991cited by this paper
• Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a pilot study which raises important questions.

  1991cited by this paper
• Chimeric BCR-abl messenger RNA as a marker for minimal residual disease in patients transplanted for Philadelphia chromosome-positive acute lymphoblastic leukemia.

  1991cited by this paper
• Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity.

  1991cited by this paper
• Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia.

  1990cited by this paper
• Clinical relevance of cytogenetics in acute leukemia.

  1990cited by this paper
• High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia.

  1990cited by this paper
• High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy.

  1990cited by this paper
• Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia

  1990cited by this paper
• Importance of long-term follow-up in evaluating treatment regimens for adults with acute lymphoblastic leukemia.

  1990cited by this paper
• Myeloid surface antigen expression in adult acute lymphoblastic leukemia.

  1990cited by this paper
• Comparison of outcome, clinical, laboratory, and immunological features in 164 children and adults with T-ALL. The Groupe d'Etude Immunologique des Leucémies.

  1990cited by this paper
• Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia.

  1990cited by this paper
• Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy.

  1989cited by this paper
• Expression of the mdr-1/P-170 gene in patients with acute lymphoblastic leukemia.

  1989cited by this paper
• Burkitt cell acute leukaemia (L3 ALL) in adults: a report of 18 cases

  1989cited by this paper
• Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysis.

  1989cited by this paper
• Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia.

  1989cited by this paper
• Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocol.

  1989cited by this paper
• Treatment of Ph-positive acute lymphoblastic leukemia with alpha-interferon.

  1988cited by this paper
• A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969.

  1988cited by this paper
• Aggressive treatment improves survival in adult acute lymphoblastic leukemia

  1988cited by this paper
• Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia.

  1988cited by this paper
• Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia.

  1987cited by this paper
• Cytosine arabinoside for induction, salvage, and consolidation therapy of adult acute lymphoblastic leukemia.

  1987cited by this paper
• Treatment of 218 adult acute lymphoblastic leukemias.

  1987cited by this paper
• Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T‐cell leukemia

  1987cited by this paper
• Acute lymphoblastic leukemia in adults: recent progress, future directions.

  1987cited by this paper
• Treatment of acute lymphoblastic leukaemia in adults

  1986cited by this paper
• Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.

  1986cited by this paper
• Remission induction of meningeal leukemia with high-dose intravenous methotrexate.

  1985cited by this paper
• Acute lymphoblastic leukemia in adults.

  1985cited by this paper
• Current status of ALL/AUL therapy in adults.

  1984cited by this paper
• E‐rosette positive acute lymphoblastic leukaemia in adolescents and adults

  1983cited by this paper
• Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children.

  1983cited by this paper
• Adult acute lymphoblastic leukemia. Response to therapy according to presenting features in 62 patients.

  1982cited by this paper
• Prognostic value of immunologic markers in adults with acute lymphoblastic leukemia.

  1978cited by this paper
• Evaluation of induction of remission, intensification, and central nervous system prophylactic treatment in acute lymphoblastic leukemia

  1974cited by this paper

• FDA Approval Summary: Blinatumomab for the Treatment of B-cell Precursor Acute Lymphoblastic Leukemia in the Consolidation Phase of Multiphase Chemotherapy.

  2025cites this paper
• Chinese a Nti鄄 Cancer a Ssociation

  2013cites this paper
• MECHANISMS OF RESISTANCE TO TYROSINE KINASE INHIBITORS IN PHILADELPHIA-POSITIVE ACUTE LYMPHBLASTIC LEUKAEMIA (ALL): FROM GENETIC ALTERATIONS TO IMPAIRED RNA EDITING

  2008influential citation
• Comparison of mRNA abundance quantified by gene expression profiling and percentage of positive cells using immunophenotyping for diagnostic antigens in acute and chronic leukemias

  2006cites this paper
• Nachweis von Deletionen der Tumorsuppressorgene TP53 und p16 mittels Fluoreszenz-In-Situ-Hybridisierung bei erwachsenen Patienten mit Philadelphia-Chromosom- positiver akuter lymphatischer Leukämie (ALL)

  2006cites this paper
• Adult acute lymphoblastic leukaemia.

  2004cites this paper
• Adult T‐biphenotypic acute leukaemia: clinical and biological features and outcome

  2003cites this paper
• Treatment of Acute Leukemias

  2003influential citation
• Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia.

  2002cites this paper
• Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia

  2002cites this paper
• Bcr-Abl variants: biological and clinical aspects.

  2002cites this paper
• Immunophenotypic analysis of acute lymphocytic leukemia.

  2002cites this paper
• Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome.

  2001influential citation
• Treatment of acute leukemia.

  1999cites this paper
• Leukaemia‐associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcome

  1999cites this paper
• The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties

  1998cites this paper
• Renal complications in acute leukemias.

  1998cites this paper
• Levels of expression of CAF7 (CD98) have prognostic significance in adult acute leukemia.

  1998cites this paper
• Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.

  1998cites this paper
• T‐Lymphocyte Functions in Acute Leukaemia Patients with Severe Chemotherapy‐Induced Cytopenia: Characterization of Clonogenic T‐Cell Proliferation

  1998cites this paper
• Anthracyclines in haematology: pharmacokinetics and clinical studies.

  1998cites this paper
• Akute lymphatische Leukämie des Erwachsenen

  1998cites this paper
• Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group.

  1997cites this paper
• Current trials in acute leukaemia.

  1996cites this paper